Biotech startup Immunai picks up $60m Series A: TechCrunch
Immunai, a biotech startup, has raised $60 million in Series A funding, according to TechCrunch.
Immunai, a biotech startup, has raised $60 million in Series A funding, according to TechCrunch.
Copyright PEI Media
Not for publication, email or dissemination